Skip to main content

AstraZeneca

By Laura Lovett | 02:40 pm | August 04, 2020
The companies will also be looking into using Eko's tech in clinical trials. 
By Dave Muoio | 04:19 pm | May 26, 2020
The digital respiratory health company says this deal and clearance now give it access to 90% of the U.S. asthma and COPD market.
By Dave Muoio | 04:50 pm | March 30, 2020
Also: Providence supporting COVID-19 patients at home with Xealth and Twistle; Lief Therapeutics incorporates DrChrono's Open API.
By Leontina Postelnicu | 07:45 am | November 28, 2019
The initiative is based on a strategic partnership between the company and Jerusalem Venture Partners, Microsoft, Israeli entrepreneur Morris Kahn and others.
By Tammy Lovell | 05:52 am | March 20, 2019
Funds will be used to acquire more data sets and develop AI analysis.